Cargando…
Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
There is an urgent need for effective molecular therapies for hepatocellular carcinoma (HCC), the third-leading cause of cancer-related deaths worldwide. Norcantharidin (NCTD), a demethylated derivative of cantharidin, reportedly exhibits anticancer activity against various types of tumors, includin...
Autores principales: | Sun, Chao-Yue, Zhu, Ying, Li, Xiao-Feng, Tang, Li-Peng, Su, Zu-Qing, Wang, Xie-Qi, Li, Cai-Yun, Yang, Hong-Mei, Zheng, Guang-Juan, Feng, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777744/ https://www.ncbi.nlm.nih.gov/pubmed/29383132 http://dx.doi.org/10.18632/oncotarget.22935 |
Ejemplares similares
-
Norcantharidin inhibits proliferation and promotes apoptosis via c‐Met/Akt/mTOR pathway in human osteosarcoma cells
por: Mei, Liangwei, et al.
Publicado: (2019) -
Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity
por: Yao, Chong, et al.
Publicado: (2018) -
Larotrectinib induces autophagic cell death through AMPK/mTOR signalling in colon cancer
por: Kong, Wencheng, et al.
Publicado: (2022) -
Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
por: Wang, Lei, et al.
Publicado: (2022) -
Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)